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The proposed human intestinal absorption prediction model is applied to over 900 
pharmaceuticals and has about 82.5% true prediction power. This study will provide a 
screening tool that can differentiate well-absorbed and poorly-absorbed drugs in the 
early stage of drug discovery and development. This model is based on fundamental 
physicochemical properties and can be applied to virtual compounds. The maximum well-
absorbed dose (i.e., the maximum dose that will be more than 50 percent absorbed) 








New drug discovery and development is unquestionably a very costly process and has no 
assurance of clinical or commercial success. According to DiMasi et al. [1] and Kaitin and 
DiMasi,[2] the average total cost for developing new chemical entities (NCEs) is almost 
800 million dollars and requires decade-long research. On the other hand, the rate at 
which NCEs are generated is increasing exponentially with the advancement in chemistry 
and high-throughput screening [3]. Only a small fraction of these synthesized drugs reach 
the market. Any step that could speed-up this development process will be beneficial. A 
primary reason for the high attrition of drugs in development is associated with sub-
optimal absorption. Predicting human intestinal absorption (HIA) is a challenging task 
because the absorption of drugs from the gastrointestinal (GI) tract is a complex function 
of many physicochemical, physiological and pharmaceutical factors, i.e.; solubility, 
permeability, stability, surface area, pH, pKa, GI blood flow, GI transit time, luminal 
volume, membrane transport mechanisms and types of dosage forms [4].  
 
Any model that attempts to account for all of these factors will be extremely complicated 
and not feasible to use in the initial phase of drug discovery. There are various in vivo and 
in-vitro models proposed in the scientific literature for predicting human intestinal 
absorptions. However, many parameters that are required for prediction may not be 
available in the early stage of drug discovery and development. On the other hand, 
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computational models are applicable to the design of new drugs [5]. Many computational 
models utilize a large variety of molecular descriptors, however this may lead to over-
fitting which can lower predictability for future compounds. On the other hand, 
physicochemical property-based computational models are simple and intuitive.  
 
It is well known that solubility and octanol-water distribution coefficient are the two main 
factors that govern absorption. This work will utilize the intrinsic product as the key 
driving force that governs human intestinal absorption. Ni et al. [6] have shown that this 
product is equal to the product of the intrinsic solubility and the intrinsic octanol-water 
partition coefficient. Using the general solubility equation (GSE) [7], the intrinsic product 














1.1 Background on Physicochemical Properties and Useful Equations Associated 
with the Proposed Models 
 
 Human intestinal drug absorption is a complex process, and it depends on several basic 
physicochemical properties, such as aqueous solubility, octanol-water partition 
coefficient, melting point, octanol solubility, pH, pKa, and intrinsic product. In order to 
understand the proposed models clearly, it is worth reviewing the fundamental 
relationships among these properties. 
 
1.1.1 Henderson–Hasselbalch Equation 
 
One of the most well-known relationships between pH and pKa is described by the 
Henderson–Hasselbalch equation. [8]  
For weak acids, 
 
pH =  pKa +  log
[A−]
[HA]
                    (Equation 1.1) 
 
where pH is the negative logarithm of the hydrogen ion concentration, pKa is the negative 
logarithm of the equilibrium constant of a weak acid, [HA] is the molar concentration of 
the undissociated weak acid, and [A⁻] is the molar concentration of the conjugate base.  
17 
 
1.1.2 Ideal Solubility of the Crystalline Solute 
 
Solubility is a very important factor that plays a critical role in drug absorption process, 
since in order to the drug to be orally absorbed it must be dissolved and available as a 
solution in GI lumen. Various other key parameters associated with solubility, i.e., 
dissolution rate, particle size, wettability.  
 
The solubility of a solid in any solvent depends mainly on two factors: the ideal solubility 
of the crystal and the interaction between the solute and the solvent. According to the 
Hildebrand and Scott [9] or the Clausius-Clapeyron equation,[10] the ideal solubility, Xu
i , 
of a crystalline substance can be expressed as 
 
log Xu
i =  −∆Hm (
(Tm−T)
 2.303RTTm









 )    (Equation 1.2) 
 
where ∆𝐻𝑚 is the molar heat of melting, ∆Cpm is the heat capacity difference between 
the solid and the molten forms of the solute, R is the gas constant, T and Tm are the room 
temperature and melting point in Kelvin, respectively. 











)        (Equation 1.3) 
 
Since, at the melting point, the Gibbs free energy of melting,  ∆Gm, is equal to 
zero, ∆Hm/Tm can be replaced by the entropy of fusion, ∆Sm, So 
 
log Xu
i =  −∆Sm (
Tm−T
 2.303RT
)        (Equation 1.4) 
 
This equation can be further simplified by incorporating Walden’s Rule [12] (∆𝑆𝑚 is 56.5 
J/ degree mole for most of the organic molecules) 
 
log Xu
i =  −0.01 (Tm − T )        (Equation 1.5) 
 
where T and Tm are the room temperature and the melting point in degrees Kelvin, 
respectively. 
The ideal solubility of crystalline solute at the room temperature is 
 
log Xu




where MP is the melting point in degrees Celsius. 
 
1.1.3 Octanol-Water Partition Coefficient 
 
The octanol-water partition coefficient is simply defined as  
 
Kow =  
ao
aw
          (Equation 1.7) 
 
where 𝑎𝑜 and 𝑎𝑤 are the activities of a solute in octanol and water, respectively. 
Assuming there is no self-association of the solute in either phase and a negligible effect 
of mutual saturation of the phases, the 𝐾𝑜𝑤 can be approximated by the solubility ratio 
of the two phases 
 
Kow =  
So
Sw
          (Equation 1.8) 
 
In logarithmic terms, 
           




For compounds that are completely miscible with octanol, Jain and Yalkowsky (2001) [7] 
proposed that the logarithmic octanol solubility can be approximated as a mole fraction 
value of 0.5.  Pure octanol is 6.3 molar, and if a solute of similar size is miscible with 
octanol, it should have a solubility of at least 3.15 molar. Replacing log So with 0.5, which 





L = 0.5 − log Kow                  (Equation 1.10) 
 
1.1.4 General Solubility Equation (GSE) 
 
According to Yalkowsky, [7] the solubility of a crystal in water is equal to the solubility of 
the liquid in water multiplied by the ideal solubility of the crystalline solute. Thus  
 
log Sw
C =  log Sw
L  + log Xu
i                    (Equation 1.11) 
 
The GSE is generated by substituting Equation 1.6 and 1.10 into Equation 1.11. 
 




The GSE requires only the octanol-water partition coefficient and the experimental 
melting point to predict the aqueous solubility of a crystalline nonelectrolyte. 
 
1.1.5 Intrinsic Product 
 
A newly defined parameter, the intrinsic product, is the product of the intrinsic solubility 
and the intrinsic partition-coefficient, therefore 
Intrinsic product = Sw ∗ Kow 
This product can be explained in the term of the GSE by rearranging Equation 1.12. Hence  
 
 log Sw +  log Kow = 0.5 − 0.01(MP − 25)                  (Equation 1.13) 
 
Solving for the Intrinsic product, 
 
 log(Sw ∗  Kow) = 0.75 − 0.01(MP)                 (Equation 1.14) 
 




Intrinsic product = (Sw ∗  Kow) = 10
0.75−0.01(MP)               (Equation 1.15) 
 
By applying the solubility ratio approximation for the octanol-water partition coefficient 
(Equation 1.8), the intrinsic product can also be written as 
 
Intrinsic product = (Sw ∗  Kow) = (Sw ∗  
So
Sw
) =  So                 (Equation 1.16) 
 
where So is the octanol solubility of the crystalline solute. 
According to Sepassi and Yalkowsky [13] and Admire and Yalkowsky, [14] the octanol 
solubility of a crystalline solute can be described by Equation 1.17 assuming its 
hypothetical super-cooled liquid is miscible with octanol, 
  
log S0 = −∆Sm (
Tm−T
 2.303RT
) + 0.5                 (Equation 1.17) 
 
It is important to note that this equation is entirely analogous to Equation 1.11 which 
gives the solubility of the crystalline solute in water instead of octanol. In other words 
 
log So
C =  log Xu
i +  log So





A RULE OF UNITY FOR HUMAN INTESTINAL ABSORPTION: 




In this chapter, the efficiency of human intestinal absorption (HIA) of 59 drugs which are 
marketed as salts is predicted using the rule of unity. Intrinsic aqueous solubilities and 
partition coefficients along with the drug dose are used to calculate modified absorption 
potential (MAP) values. The application of the rule of unity to over 900 pharmaceutical 
drugs will be discussed in detail in Chapter 3. The MAP values are shown to be related to 
the fraction of the dose that is absorbed upon oral administration in humans (FA). It is 
shown that the MAP value can distinguish between drugs that are poorly absorbed (FA 
<0.5) and those that are well absorbed (FA ≥ 0.5). Inspection of the data as well as a 
receiver operative characteristic (ROC) plot show that a single critical MAP value can be 
used for predicting efficient human absorption of drugs. The rule of unity based on simple 










2.1.1 Absorption Potential 
 
The concept of absorption potential, based solely on in vitro data, was first introduced 
by Dressman et al. [1] (1985) to assess the likelihood of an orally administered drug 
to be well absorbed. Balon et al. [2] (1999) defined the human intestinal absorption 
potential, AP, of a drug as, 
 









6.8are the total solubility in water and the octanol-water distribution 
coefficient, respectively, of the drug at pH 6.8.  He showed a correlation between this 
absorption potential and the fraction absorbed of a series of drugs.  If the gastro intestinal 
(GI) luminal volume (𝑉𝐿)  is assumed to be 0.250 L, this becomes 
 





)                     (Equation 2.2) 
 
Shortly thereafter, Ni et al. [3] (2002) showed that the product of the solubility of a 
compound in water at any pH (𝑆𝑇
𝑝𝐻) and the octanol-water distribution coefficient at the 
same pH (𝐾𝐷
𝑝𝐻) is equal to the product of the intrinsic solubility (𝑆𝑤









𝑖𝑛𝑡       (Equation 2.3) 
 
They demonstrated that this relationship is valid over a wide pH range for zwitterions as 
well as weak acids and weak bases. As illustrated in Figure 2.1, any change in solubility 
with pH is accompanied by an equal in magnitude and opposite in direction change in 
partition coefficient. Therefore, the intrinsic product (𝑆𝑤
𝑖𝑛𝑡 ∗ 𝐾𝑜𝑤
𝑖𝑛𝑡) is the effective driving 
force for membrane transport.  Its constancy greatly facilitates the calculation of the 
absorption potential by eliminating the need to know the pKa of the compound or the pH 














































































2.1.2 Modified Absorption Potential 
 
Replacing the solubility and partition coefficient in Equation 2.1 with the intrinsic product, 
Sanghvi et al. (2001) [4] defined a modified absorption potential as, 
 





)        (Equation 2.4) 
 
If the administered dose is soluble in the 0.250 liters of the GI tract, then the dissolved 
drug concentration, CL, is equal to 4* Dose. Therefore, 
 





𝑖𝑛𝑡                   (Equation 2.5) 
 
For drugs that are completely dissolved in the GI tract at a given dose, MAP is calculated 
using Equation 2.5, while Equation 2.4 is used to calculate MAP for drugs that are not 
completely dissolved at a given dose. (Note, if the dose is in grams, then both the drug 
concentration and the drug solubility must be in grams per liter.) 
 
Sanghvi et al. (2001; 2003) [4, 5], Yalkowsky et al. (2006) [6], and Chu and Yalkowsky 
(2009) [7] have demonstrated that plots of MAP vs. FA are sigmoidal. The FA values can 
be characterized as either well absorbed (FA ≥ 0.5) or poorly absorbed (FA < 0.5) by the 
rule of unity, i.e., whether the value of MAP is greater than or less than zero. These studies 
28 
 
were performed on non-electrolyte drugs which were given as suspensions and were 
reported to be passively absorbed after oral administration. 
According to Equation 2.3, the intrinsic product (𝑆𝑤
𝑖𝑛𝑡 ∗ 𝐾𝑜𝑤
𝑖𝑛𝑡) is the same for an ionized 
weak electrolyte and its uncharged form. Therefore, whether the drug is in the salt or 
uncharged form, its absorption is related to its intrinsic product. In this work, the rule of 
unity is applied to pharmaceutical salts, where MAP values are calculated using the 
intrinsic product. Therefore, there was no need to know the pH of the microenvironment 


























2.2.1 Absorption Data 
 
Experimental values of absorption data for various pharmaceutical salts were obtained 
from a well-known human intestinal absorption database developed by Hou et al. (2007) 
[8]. In the database, 578 drugs were reported to be absorbed through passive diffusion. 
However, the current work only focuses on 59 drugs that are marketed as salts and for 
which experimental fraction absorbed (FA) values are available in the literature. In Table 
2.1, the first 29 drugs have dose values such that they form a solution in the GI tract while 
the rest of the drugs form a suspension in the GI tract. The drug salts and their FA values 




Most of the drug doses were collected from the FDA’s Maximum Recommended 
Therapeutic Dose (MRTD) database [9]. This database was chosen because most values 
in the database were determined from pharmaceutical clinical trials that employed an 
oral route of exposure. Moreover, most values were normalized for the average adult 
weighing 60 kg. The MRTD values which were in mg/kg were converted into mol/60kg 
dose. If the dose was not available in the database, then the dose listed in either 






2.2.3 Physical Data 
 
All partition coefficients and intrinsic solubilities were calculated using ACDLABS 9.0 [12]. 
The primary algorithm for calculating partition coefficients used by ACDLABS is based on 
the principle of isolating carbons [13]. The algorithm for intrinsic solubility is not 
published. 
 
2.2.4 Statistical Analysis 
 
To predict whether a drug is well absorbed or poorly absorbed, Receiver Operative 
Characteristic (ROC) analysis was performed. The ROC analysis is a qualitative evaluation 
tool that can be used for a binary classifier system (“yes” or “no” type outcomes). The 
ROC curve is a plot of the fraction of true positives out of all positive prediction 
(sensitivity) vs. the fraction of false positive out of all negative predictions (specificity), at 
various threshold settings. IBM SPSS version 21 was used to generate the ROC curve with 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3 Results and Discussion 
 
Figure. 2.2 shows the plot of FA vs. MAP for the 59 salts studied. The figure is divided into 
four quadrants.  The points in the upper right (True Positive) and lower left (True negative) 
represent correct predictions of high and low absorption efficiency.  The points in the 
lower right (False positive) and upper left (False negative) quadrants represent incorrect 
predictions. Also, the prediction power of this model is more accurate when the MAP 
value is higher than 2 or lower than -2. The MAP is a simple absorption parameter which 
is a good indicator of absorption efficiency of salts, and there is no need to know about 
the total solubility, distribution coefficient or dissociation constant of the drug.  
 
In Figure 2.2, the rule of unity is represented by the bold vertical line which is a simple 
delineator that can differentiate between poorly absorbed and well-absorbed drugs. A 
more appropriate delineator value for this data set was found using ROC curve analysis. 
As described earlier, the ROC curve analysis can be used to determine the most 
appropriate cut-off value for a set of binary data, i.e., data that can be represented as yes 
or no. Therefore, it can be used to distinguish between poorly absorbed and well-
absorbed drugs. Using calculated MAP values, a ROC curve, (Figure 2.3), was created to 
determine the MAP value that has the highest model sensitivity (Probability of finding 
high MAP values when good absorption has been reported) and specificity (Probability of 




The ROC curve was generated by plotting the calculated sensitivity on the Y-axis and 
plotting the calculated 1- specificity on the X-axis. The sensitivity and specificity were 
calculated by 
Sensitivity =  
# of correct positive predictions
Total # of positive predictions
 
and 
Specificity =  
# of correct negative predictions








































































































































































In Figure 2.3, the circle represents the maximum product of the sensitivity (0.953) and 
specificity (0.875). This point corresponds to best delineating MAP value which is -0.973. 
This new value, which is represented by a dashed line in Figure 2.2 is statistically more 
accurate than zero and may be used as a new delineator for the rule of unity. In other 
words, if the calculated MAP value is higher than -0.973, it is more likely that the drug is 
well absorbed. The shaded fraction of the ROC curve, approximately 0.968, which can be 
considered approximately analogous to the R-square value of a regression line, confirms 
the strength of this model.  
 
The human intestinal absorption results for the salts studied are summarized in Table 2.2. 
Clearly, there is a good correlation between the observed FA and predicted MAP values 
for the whole data set as well as subsets. The cut-off value of zero is used to differentiate 
well-absorbed and poorly absorbed compounds in this model.  
 
Overall, 91.5% of the predictions of this model are correct. The above results are further 
confirmed by the data of Avdeef et al. (2008) [15]. They studied the effect of accurately 
measured solubility and an artificial membrane permeability (PAMPA), on the absorption 
of sparingly soluble drugs. They observed that at a high dose, where the drug is not 
completely dissolved, the absorption flux is constant as the pH-permeability, and pH-
solubility curves mirror each other. They also observed that at a low dose where the drug 







Table 2.2 Human Intestinal Absorption Prediction Results for Salts 
 
Category True Prediction False Prediction Total 
Solution (4D  Sw) 25 4 29 
Suspension (4D > Sw) 29 1 30 



















The absorption efficiency of salts can be characterized based on a simple MAP value which 
is a function of the drug dose and calculated or observed aqueous solubilities and 
partition coefficients. However, this calculation is solely based on physical data and may 
not account for physiological conditions along the GI tract or dissolution kinetics of drug 
formulations. 
 
If the value of the MAP is greater than zero, the salts are generally well (> 50%) absorbed, 
and if it is less than zero, the salts tend to be poorly absorbed. The human intestinal 
absorption was predicted correctly for 54 out of total 59 salts used in this model. Thus, 
the rule of unity could be utilized as a pre-screening tool for predicting human intestinal 







A RULE OF UNITY FOR HUMAN INTESTINAL ABSORPTION: 




The rule of unity is based on a simple absorption parameter, , that can accurately 
predict whether an orally administered drug will be well absorbed or poorly absorbed. 
In this chapter, the intrinsic aqueous solubility and octanol-water partition coefficient, 
along with the drug dose are used to calculate . We show that a single delineator value 
for  exists that can distinguish whether a drug is likely to be well absorbed (FA ≥ 0.5) 
or poorly absorbed (FA < 0.5) at any specified dose. The model is shown to give 82.5 
percent correct predictions for over 938 pharmaceuticals. The maximum well-absorbed 
dose (i.e., the maximum dose that will be more than 50 percent absorbed) calculated 











New drug discovery and development is unquestionably a very costly process, with only 
a small fraction of synthesized drugs reaching the market. According to DiMasi et al. [1] 
and Kaitin and DiMasi [2], in 2011, the average total cost for developing new chemical 
entities (NCEs) is almost 800 million dollars and requires decades-long research. The 
primary reason for the high attrition of drugs in development is associated with sub-
optimal absorption. 
 
Predicting human intestinal absorption (HIA) is a challenging task because the absorption 
of drugs from the gastrointestinal (GI) tract is a complex function of many 
physicochemical, physiological and pharmaceutical factors. Including; drug solubility, 
permeability, pKa, dose, GI luminal volume, and pH. [4] The proposed simple and intuitive 
approach uses only the aqueous solubility, octanol-water partition coefficient, and dose 
of the drug as input. 
 
3.1.1 Membrane Transport Model 
 
The transport rate (or flux) of a drug from the GI lumen through the GI membrane into 
the blood can be described by the physical model of Stehle and Higuchi (1972) [15], i.e.,  
  
𝐹 ∝ ∆𝐶×𝐾𝑜𝑤          (Equation 3.1) 
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where F is the flux from a solution, C is the concentration difference between the gut 
and the blood, and 𝐾𝑜𝑤 is the membrane-water partition coefficient of the drug which is 
assumed to be identical to the octanol-water partition coefficient.  
 
3.1.2 Absorption Potential 
 
In 1985, Dressman et al. [16] introduced the concept of absorption potential. Using in 
vitro data for seven drugs, they showed the interrelation of drug dose, partition 
coefficient, and solubility to the fraction of the dose absorbed. They defined the 
absorption potential, APDressman, as, 




)     (Equation 3.2) 
 
where, Fnon is the fraction in the nonionized form at pH 6.5, Sw
int is the intrinsic solubility 
of the nonionized species at 37oC, D is the dose administered, and  VL is the intestinal 
luminal volume. 
 
Balon et al. [17] (1999) further developed the  human intestinal absorption potential 
model by modifying the numerator of the above equation so that the solubility and the 
partition coefficient both reflect the same physiological pH, i.e., 
  










6.8are the solubility in water and the octanol-water distribution 
coefficient, respectively, of the drug at pH 6.8. 
 
If the gastrointestinal (GI) luminal volume (VL) is assumed to be 0.250 L, and the drug is 
not completely dissolved, we can define the absorption potential of a suspension, AP𝑠𝑢𝑠𝑝, 
as 
 





)                                (Equation 3.4) 
 
3.1.3 Intrinsic Product 
 
Ni et al. [6] (2003) observed an important relationship between the pH, partition 
coefficient, and solubility. They showed that the product of the total solubility of a 
compound in water at any pH (ST
pH
) and the octanol-water distribution coefficient at the 
same pH (KD
pH
) is equal to the product of the intrinsic solubility (Sw
int) and the intrinsic 
partition coefficient (Kow








int        (Equation 3.5) 
 
Note, that the above equation assumes that salt precipitation and ion pair partitioning 
are not significant. They demonstrated that this relationship was valid for 25 compounds 
comprising zwitterions as well as weak acids and weak bases over a wide pH range. 
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Therefore, the intrinsic product (Sw
int ∗ Kow
int ) is the effective driving force for membrane 
transport. Its constancy greatly facilitates the calculation of the human intestinal 
absorption by eliminating the need to know the pKa of the compound or the pH of the 
gastrointestinal tract microenvironment.  
 
3.1.4 Modified Absorption Potential 
 
Sanghvi et al. [18] (2001) introduced the modified absorption potential by replacing the 
solubility and partition coefficient with the intrinsic product, therefore, 
 





)                                                                                  (Equation 3.6) 
 
where MAP𝑠𝑢𝑠𝑝 is the modified absorption potential for an incompletely dissolved drug. 
This eliminates the need to know the 𝑝𝐾𝑎 of the drug or the pH of the luminal 
microenvironment. In addition, the experimentally measured intrinsic values are more 
reliable than fixed pH measurements.  
 
Later Sanghvi et al. [19] (2003) showed that the MAP model could be divided broadly into 
two categories based on whether the orally administered dose forms a solution or a 






3.1.4.1 Drugs that form solutions at their administered dose ( 4D ≤ Sw ) 
 
If the drug is completely soluble in the volume of GI luminal fluid, then the aqueous 
solubility, Sw, can be replaced by the concentration of the drug in the GI luminal fluid, CL. 
Typically, this volume is assumed to be 0.25 L. Thus, for any dose that can be dissolved 
completely in 0.25L of the GI fluid, 
 
Sw =  
D
0.25
= 4D                     (Equation 3.7) 
 
therefore, the MAP values for a solution can be calculated simply by replacing Sw
int
 in  
Equation 3.6 with 4D. 
 





int                                (Equation 3.8) 
 
3.1.4.2 Drugs that forms suspensions at their administered dose (4D > Sw) 
 
Drugs that do not dissolve completely in the volume of aqueous GI luminal fluid form a 
suspension in the gut. Thus, assuming the drug does not form a supersaturated solution, 
the maximum dose that can be dissolved is equal to its intrinsic solubility. The MAP values 
for a suspension can be calculated using the equation below, 
 





)                    (Equation 3.9) 
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For slightly supersaturated solution this is only true for the initial phase until the 
supersaturated solution becomes a true solution. (Note that if the dose is in grams, then 
both the drug concentration and the drug solubility must be in grams per liter) 
 
3.1.5 Luminal Oversaturation Number and Development of Absorption Parameter  
 
Sanghvi et al. [19] (2003) introduced the rule of unity and developed a new unitless 
parameter called luminal oversaturation number, OLumen, which reflects the degree of 
oversaturation of the GI luminal fluid by drugs. It is defined as, 
 
OLumen = max (
4D
Sw
int , 1)                  (Equation 3.10) 
 
Thus, the luminal oversaturation number offers a convenient means to differentiate high 
and low solubility drugs. It is defined similarly to the dose number. However, it cannot be 
less than unity. Daousani and Macheras [20] observed that the ratio of dose to solubility 
is not a constant parameter and it is a key driving force in the drug dissolution process. 
 
Using OLumen, they developed a more intuitive absorption parameter, , which is the 
logarithmic ratio of the partition coefficient and the unitless oversaturation number. This 
parameter applies to both suspended and dissolved drugs. 
 




) =MAPsol – log OLumen= MAPsusp              (Equation 3.11) 
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It is worth noting that the absorption parameter  (Equation 3.11), becomes either 
Equation 3.8 or Equation 3.9, based on the whether the drug is forming a solution or a 
suspension in the GI tract at the administered dose. The above results are further 
confirmed by the data of Avdeef et al. [21] They studied the effect of accurately measured 
solubility and an artificial membrane permeability (PAMPA) model, on the absorption of 
sparingly soluble drugs. Their data show that at a high dose, where the drug is not 
completely dissolved, the absorption flux is constant as the pH-permeability, and pH-
solubility curves mirror each other. Their data also show that at a low dose where the 
drug is completely dissolved, the absorption flux is a function of the effective 
permeability. 
 
3.1.6 Human intestinal absorption and membrane transport mechanisms 
 
The small intestine acts as the main absorption site for many orally administered drugs. 
As shown in Figure 3.1, these drug molecules can cross human intestinal membrane by 
one or more of following mechanisms; passive diffusion, facilitated diffusion, paracellular 
transport, transcellular transport, active influx, and active efflux.  
Passive diffusion is energy independent and concentration gradient based transfer of 
drug molecules across the membrane. In other words, the drug molecules move across 
the cell membrane from a high concentration to a low concentration. This process is 




= 𝐷 𝐴 𝑃 
𝑑𝐶
𝑑𝑋






 is the rate of diffusion, D is the diffusion coefficient, A is the surface area of the 
membrane, P is the permeability, 
𝑑𝐶
𝑑𝑋
 is the concentration gradient across the membrane. 
Venous blood is continuously flowing which maintains sink conditions across the cell 
membrane. This condition is a driving force for the passive diffusion. [22-25] 
 
Facilitated diffusion is a passive transport in which drug molecule is diffused via specific 
transmembrane proteins. In paracellular transport, the drug molecule is carried by 
passing through the space between the enterocyte cells. This route is more selective for 
small (MW<200), hydrophilic (log𝐾𝑂𝑊<0), cationic drugs due to the characteristic water 
pores and tight junctions [23,26].  In transcellular transport, the drug molecule permeates 
the apical membrane of the enterocyte, diffuses through the cell, and diffuses out 
through the basolateral membrane to be absorbed into the blood. The transcellular 
transport comprises of transcellular diffusion, endocytosis, exocytosis, and/or active 






































The process of active transport is energy dependent and against the concentration 
gradient. In other words, the drug molecules move across the cell membrane from lower 
concentration to higher concentration. In a nutshell, the process of active influx means 
transporters on the membrane increase the drug concentrations into the cell, and active 
efflux transport means transporters on the membrane decrease the drug concentrations 
inside the cell. Both influx and efflux transporters are important in drug design. Many 
researchers suggest that the drug absorption can be improved by manipulating active 
influx transporters. [27-29] Some researchers indicate that drug absorption can also be 
improved by avoiding potential substrate of efflux transporters. [30,31] It is worth 
mentioning that compared to passive transport carrier-mediated active transport can be 
quickly saturated. There are two different opinions regarding drug transport mechanisms. 
According to one group, multiple absorption mechanisms coexist for the oral absorption 








3.2.1 Compound selection 
 
The rule of unity model by Sanghvi et al. [19] and Yalkowsky et al. [37] only applies to 
nonelectrolyte drugs which were reported to be passively absorbed after oral 
administration. To make a more robust and a more generalized model, we have 
incorporated all kinds of pharmaceuticals including salts, nonelectrolytes, or drugs that 
are reported to undergo active influx or efflux. 
 
3.2.2 Fraction Absorbed Data 
 
Experimental values of oral absorption for a diverse group of pharmaceuticals were 
obtained from the well-known critically evaluated human intestinal absorption databases 
developed by Hou et al. [38], Newby et al. [39] and other scientific literature. [3,19,40] 
When FA values were reported as a range or when more than one value was reported; 
the mean value was adopted in this database. The fraction absorbed data are given in 
supplementary information in Table A.1 along with the physical property data and the 
Maximum Recommended Therapeutic Dose (MRTD) values for each compound. It is 
noted that the reported FA values are skewed towards being well-absorbed because 






3.2.3 Drug dose data 
 
Most of the drug doses were collected from the FDA’s MRTD database. [41] This database 
was chosen because most of its values were determined from the results of 
pharmaceutical clinical trials. Moreover, these values are normalized for the average 
adult weighing 60 kg. If the dose was not available in the database, then the dose listed 
in Micromedex [42], Lexicomp [43], Newby et al. [39], or other scientific literature [44-54] 
was used. The relationship between FA and dose is depicted in Figure 3.2. The doses used 
formed a continuous, well-distributed dataset (8-log distribution) and there is no clear 
way one can separate the well-absorbed and poorly absorbed compounds solely based 
on their dose value.  
 
3.2.4 Physicochemical properties 
 
In order to eliminate any bias, all physicochemical properties used in the proposed model 
were collected from chemical abstract service – SciFinder [55] which were calculated 
using ACDLABS 11.02 [56] software. If values were not available in SciFinder, then ACDLAB 
7.0 [57] software was used to calculate all physicochemical properties. The group 
contribution methods like UPPER can also be utilized to calculate some physicochemical 















































































































































































































































































































































3.2.5 Calculation of   
 
The intrinsic aqueous solubility and octanol-water partition coefficient, along with the 
maximum recommended therapeutic dose (MRTD) are used to calculate the absorption 
parameter . Although  can be used to calculate any fraction absorbed, it is most 
accurate at FA = 0.5. 
 
The proposed human intestinal absorption model is a true in silico model as the  values 
are predicted only based on calculated partition coefficient and calculated intrinsic 
solubility using ACDLAB software. This work will reaffirm the relationship between the 
intrinsic product (Sw
int ∗ Kow
int ) and the dose and the experimental values of human 
intestinal absorption. (Note, that Sanghvi et al. used some log Sw values that were 
experimentally determined, and some that were calculated from the general solubility 
equation [7].  
 
3.2.6 Statistical Analysis 
 
Addinsoft XLSTAT version18.06 [58] was used to generate the ROC curve with 95% 


























































































3.3 Results and Discussion  
 
The Correlations of the experimental FA values with the physicochemical properties used 
in this model are shown in Figure 3.2, 3.3, 3.4, and 3.5. It is evident that there is no single 
vertical delineator line that can differentiate between the pharmaceuticals that are well 
absorbed from those that are poorly absorbed for any of these properties.  
                                                                                                                                                     
Figure 3.6 is a plot of FA vs.  for the 938 Pharmaceuticals studied. The horizontal line at 
FA=0.5 differentiates the well-absorbed (FA≥0.5) and poorly absorbed (FA<0.5) 
compounds. It is clear that there is a correlation between the fraction absorbed and . It 
is also clear that the relationship between FA and  cannot be adequately described by a 
single equation. However, it is possible to define a delineator to separate well-
absorbed values from poorly absorbed values. To do this, we utilized Receiver 
Operative Characteristic (ROC) statistical analysis. The ROC analysis is a qualitative 
evaluation tool that can be used for a binary classifier system (“yes” or “no” type 




# of correct positive predictions
Total # of positive predictions







# of correct negative predictions
Total # of negative predictions




The optimum value for , is obtained from Youden’s index which is defined as  
 





















































This circle in Figure 3.7 is the point that provides the maximum sum of the sensitivity and 
specificity. It is the farthest point on the plot from the diagonal line between the origin to 
the point corresponding to both sensitivity and specificity being equal to unity. This point 
corresponds to the optimum delineating  value (-0.402). The fractional area under the 
ROC curve is approximately 0.765, which can be considered analogous to the R-square 
value of a regression line, confirms the strength of this model. 
 
In Figure 3.8, the bold vertical line at =-0.402 is a delineator generated by the ROC curve 
and which can differentiate poorly absorbed from well-absorbed drugs. In other words, if 
 value is greater than -0.402, the compound is likely to be well absorbed, and if  value 
is lower than -0.402, the compound is likely to be poorly absorbed. Using horizontal and 
vertical delineators, this Figure is divided into four quadrants. The 675 points in the upper 
right (true positive) and 99 points in the lower left (true negative) represent correct 
predictions of high and low absorption efficiency. The 68 points in the lower right (false 





























































































































































For a better understanding of the data in Figure 3.8, the bar graph with standard error is 
generated by plotting the average of the FA values within -0.5 and +0.5 log units of the  
value. This curve is shown in Figure 3.9. The bar label corresponds to the total number of 
compounds fall into that  range. We can observe that  values and the corresponding 
mean FA values have a similar trend as we move from negative region to positive region.  
 
Interestingly, a single value of  (-0.402) is equally applicable to drugs that form solution 
or suspension in the GI tract. Figure 3.10 represents the drugs that form a solution at their 
administered dose (Equation 3.8), and Figure 3.11 represents the drugs that form 
suspension at their administered dose (Equation 3.9). It is clear from these figures and 
Table 3.1 that a single  value of -0.402 can differentiate well-absorbed and poorly 
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Clearly, there is a good correlation between the observed FA and the calculated 
absorption parameter  for the whole dataset as well as for 377 drugs that are soluble in 
250 ml of GI fluid (solutions) and 561 for immiscible drugs (suspensions). Furthermore, 
the fraction of the correct predictions is similar for both groups. 
 
Overall, 82.5% of the predictions are correct. The relatively low number of reported 
poorly absorbed data is partially due to a reluctance of companies to publish negative 
results. 
 
In 1997, Lipinski et al. introduced the rule of five for rapid screening of compounds which 
has improved bioavailability. According to them, compounds would possess poor 
absorption if any two of the following conditions met; molecular weight > 500, log Kow >5, 
the number of hydrogen bond donor >5, the number of hydrogen bond acceptor > 10. To 
study outliers and whether molecular weight has a significant effect on fraction absorbed 
or not, a low molecular weight (MW < 150) compounds and high molecular weight (MW 
> 1000) compounds are plotted in Figure 3.12. It is evident from Figure 3.12 that most of 
the high molecular weight compounds have a low value of fraction absorbed and most of 
the low molecular weight compounds have a high value of fraction absorbed. To 
understand the relationship between molecular weight and fraction absorbed, as showed 
in Figure 3.13, the plot of mean FA and median molecular weight is generated. It is 
apparent from this figure that there is no significant change in mean FA value until the 
molecular weight is 400. However, we can see that increasing molecular weight above 
400 will lead to a steady decrease in mean FA value. Camenisch et al. [59] observed similar 
71 
 
trend between molecular weight and Caco-2 cell permeability, and Varma et al. observed 












































































































































































































































































As we discussed earlier, previously reported the rule of unity models were only applied 
to passively absorbed drugs. For making generalized model, the rule of unity model is 
applied to all compounds irrespective of their membrane transport mechanisms. In Figure 
3.14, the compounds used in this model are divided into three categories; reported to be 
passively absorbed, reported to have active influx transport, and reported to have active 
efflux transport. If this model is only applied to passively absorbed compounds, it has 
overall 84.8 % true prediction power. When this model is applied to all compounds 
irrespective of their transport mechanism, it still has 82.5 % true prediction power (Table 
3.1). It is evident from the overall result that this model can be applied to all compounds 
irrespective to transport mechanism without losing significant accuracy. Moreover, in 
very early stage of drug discovery and for virtual compounds, it is hard to get information 
regarding their membrane transport mechanism. Figure 3.14 shows that out of all false 
negative outliers, about 23% outliers are reported to have active influx transporter. In 
other words, based on physicochemical properties as per our model these compounds 
should be poorly absorbed. However, if active influx transport mechanism is significant, 
then that can explain why these compounds have higher fraction absorbed value than 
predicted by our model. Similarly, it is also evident from Figure 3.14 that out of all false 
positive outliers, about 19% outliers are reported to have active efflux transporter. In 
other words, based on physicochemical properties as per our model these compounds 
should be well absorbed, however, if active efflux transport mechanism is significant, it 

























































































































































































































Since this model is based only on the physical data and dose, it does not account for the 
physiological conditions of the GI tract or the dissolution kinetics of the drug.  can be 
utilized as a pre-screening tool for predicting the absorption efficiency for orally 























Table 3.1 Summary of Predictions for the Pharmaceuticals 
 
Category Total True False % True 
Solutions (4D  Sw) 377 302 75 80.1 
Suspensions (4D > Sw) 561 472 89 84.1 
Poorly absorbed (FA < 0.5) 167 99 68 59.3 
Well-absorbed (FA  0.5) 771 675 96 87.5 
Passive transport 737 625 112 84.8 
Active influx 52 29 23 55.7 
Active efflux 113 92 21 81.4 

















The absorption efficiency of drugs can be characterized based on a single  value 
which is a function of the drug dose, and the calculated aqueous solubilities, the 
calculated octanol-water partition coefficients, and the unitless luminal 
oversaturation number. If the value of the  for a drug is greater than -0.402, it is 
likely to be well (> 50%) absorbed and if  is less than -0.402, it is likely to be poorly 
absorbed (< 50%). The reported human intestinal absorption was predicted correctly 
for 774 out of total 939 compounds considered. Thus, the rule of unity could be 
utilized as a pre-screening tool in the early stage of drug discovery for predicting 

















PREDICTION OF MAXIMUM WELL-ABSORBED ORAL DOSE 




For an orally administered drug to be bioavailable, it must be efficiently absorbed from 
the GI tract. In this chapter, the maximum dose that is likely to be well-absorbed upon 
oral administration is determined using the theoretically derived MP absorption model 
which is based only on the experimental melting point and the dose of drug. MP can aid 
in the early evaluation of drug absorption efficiency. The specific delineator values of  
MP ≥ 0 utilized for calculating maximum well-absorbed dose (fraction absorbed ≥ 0.5).  
 
This human intestinal absorption model is applied to over 500 pharmaceuticals that form 
saturated solution in the gastrointestinal (GI) tract at the administered dose, and about 
84.5% of its predictions are correct. This study will provide a screening tool that can 
differentiate well-absorbed drugs in the early stage of drug discovery and development. 
The maximum well-absorbed dose calculated using this model can be utilized as a 








Predicting human intestinal absorption (HIA) is a challenging task because the absorption 
of drugs from the gastrointestinal (GI) tract is a complex function of many 
physicochemical, physiological and pharmaceutical factors. [4] Any model that attempts 
to account for all these factors will be extremely complicated and not feasible to use in 
the initial phase of drug discovery. In the proposed simple and intuitive approach, we 
utilized the melting point and dose of the drug to predict whether the drug is going to be 
well absorbed (fraction absorbed, FA ≥0.5) or not.  
 
The melting point (MP) is a fundamental physicochemical property of a compound which 
is mainly used for identification of a compound and as an indication of the compound’s 
purity. Chemists routinely report MP amongst the first experimental properties following 
the synthesis of a novel material [61]. Numerous models [16-18,62] have been reported 
in the literature that utilized physicochemical properties to predict absorption potential. 
 
The main objective of this work is to generate the ability to determine whether a specified 
dose will be well absorbed (fraction absorbed  0.5) on the basis of the experimental 









4.2.1 Steady State Membrane Transport Model 
 
In 1972, Stehle and Higuchi [15] developed a new concept of in vitro modeling for 
transport across the membrane. They modified the membrane model by adding poorly 
stirred aqueous layers adjacent to lipid membrane as additional barriers to transport. 
Using this model, they showed that transport could be limited by either passage through 
the membrane or by passage through the aqueous diffusion layers. The transport rate or 
flux across the membrane (F) is proportional to the product of the drug concentration 
gradient (C) and the membrane-water partition coefficient (Kmw) of the drug, i.e., 
 
𝐹 ∝  ∆C   Kmw                         (Equation 4.1) 
 
Flynn and Yalkowsky [63] showed that the maximum transport rate for a drug across a 
biological membrane is obtained when the donor solution is saturated with drug 
concentration and the receptor solution is maintained at near zero concentration, i.e., 
the concentration gradient of the drug is equal to its intrinsic solubility Sw
int. Therefore, 
the steady state membrane flux from saturated solutions becomes, 
 
F𝑆  ∝  Sw




where the membrane-water partition coefficient of the drug is assumed to be identical to 
the octanol-water partition coefficient (Kow). 
 
4.2.2 Absorption Potential Based Models 
 
Dressman et al. [16] (1985) proposed an absorption potential (APDressman) as, 
 




)      (Equation 4.3) 
 
where D is the drug dose, Kow is the partition coefficient, Sw
int is the intrinsic solubility at 
37oC, fnon is the fraction in the nonionized form at pH 6.5, and  VL is the intestinal luminal 
volume. 
 
Balon et al. [17] (1999) modified the numerator of the above equation and defined 
absorption potential  (APBalon ) as, 
 









6.8are the total solubility in water and the octanol-water distribution 





Assuming a GI luminal volume of 0.250 L, this becomes, 
 





)        (Equation 4.5) 
 
4.2.3 Intrinsic Product and its Significance 
 
Shortly thereafter, Ni et al. [6] showed that the product of the solubility of a compound 
in water at any pH (ST
pH
) and the octanol-water distribution coefficient at the same pH 
(KD
pH
) is equal to the product of the intrinsic solubility (Sw
int) and the intrinsic partition 
coefficient (Kow








int        (Equation 4.6) 
 
This equation is only valid when salt precipitation and ion pair partitioning are 
insignificant. This relationship holds true for weak acids, weak bases, and zwitterions over 
a wide pH range. Not only the intrinsic product of a drug is constant, but it also provides 
a valuable tool for analyzing membrane transport data.  Since any change in solubility 
with pH is accompanied by an equal increase in magnitude and opposite change in Kow, 






Using intrinsic products, Sanghvi et al. [18] (2001,2003) modified the absorption 
potential, and introduced a new absorption parameter ,, defined as, 
 





)         (Equation 4.7) 
 
4.2.4 Dose and Physicochemical Properties Based Models 
 
Both, steady state concept-based AP models and kinetic-based maximum absorbable 
dose (MAD) models by Johnson and Swindell (1996) [64] and Yu (1999) [65] utilized dose 
of the drug to predict human intestinal absorption. The drug dose is also important for 
several drugs classification based on FA, for example, the biopharmaceutics classification 
system (BCS) by Amidon et al. (1995) [66], biopharmaceutics drug disposition 
classification system (BDDCS) by Wu and Benet (2005) [67], developability classification 
system (DCS) by Butler and Dressman (2010) [68], dose-dependent biopharmaceutics 
classification system (DDBCS) by Charkoftaki et al. (2012) [69]. 
 
4.2.5 Melting Point Based Absorption Potential Model 
 
Earlier, Yalkowsky [7] developed the General Solubility Equation (GSE) which provides a 
simple means of estimating the intrinsic solubility of a crystalline solute from its octanol-
water partition coefficient and melting point.  
 
log(Sw
int) = 0.5 − 0.01 (MP − 25) − log(Kow





int ∗  Kow
int ) = 0.75 − 0.01(MP)     (Equation 4.9) 
 
where MP is the melting point in degrees Celsius. Note that if the compound is liquid at 
room temperature, the MP is assumed to be 25oC. 
 
Later, Chu and Yalkowsky [40]  combined Equation 4.7 and Equation 4.9 to give the 
melting point based absorption parameter as 
 
MP =  0.75 − 0.01𝑀𝑃 − log 4𝐷                 (Equation 4.10)  
 
where MP is the  value calculated using melting point and D is the dose in moles, since 
it is based on the saturation solubility, this equation also reflects the maximum flux across 
the membrane solely as a function of melting point and drug dose. 
 
In 1986, Schultz and Ando [70] developed a model that showed direct correlation 
between lipid membrane diffusional transport and lipophilic-eutectic parameter (𝐿𝑒). 
Their calculation is based on the lowering of the melting point of the pure compound by 
making the eutectic mixture with structurally similar impurity. They observed that 
intestinal absorption in rats and transdermal absorption in humans show excellent 





4.2.6 Maximum Well-Absorbed Dose 
 
Previously, Sanghvi et al. [18,19], Chu and Yalkowsky [40], Yalkowsky et al. [37], and Patel 
et al. [71,72] showed that when  is greater than or equal to zero, the drug is likely to be 
well absorbed (FA ≥0.5). Thus, maximum well absorbable dose for saturated solutions is, 
 





                   (Equation 4.12) 
 
According to Equation 4.12, when dose (in moles) is less than or equal to the right side of 
















4.3.1 Compound Selection 
 
The previous models [18,19,37,40,71,72] were only applied to nonelectrolyte drugs which 
were reported to be passively absorbed after oral administration. To make a more robust 
and a more generalized model, we have incorporated many types of pharmaceuticals 
including salts, nonelectrolytes, as well as the drug that forms solution or suspension at a 
given dose, or the drug that are reported to undergo active influx or efflux transport. The 
compounds which do not follow the GSE assumptions were removed from the overall 
database. 
 
4.3.2 Fraction Absorbed Data 
 
Most of the experimental FA values were obtained from Hou et al. [38] and Newby et al. 
[39] When more than one value was reported, or the value was reported as a range, the 
mean value was used in this database. The fraction absorbed data are given in 
supplementary information Table A.2 along with the physical property data and the 
Maximum Recommended Therapeutic Dose (MRTD) values for each compound. It is 
noted that the reported FA values are skewed towards well-absorbed values largely 





4.3.3 Log Kow 
 
To eliminate any bias, all log Kow values were collected from chemical abstract service – 
SciFinder [55] which were calculated using ACDLABS 11.02 software. If values were not 
available in SciFinder, then ACDLAB 7.0 [57] software was used to calculate all 
physicochemical properties. 
 
4.3.4 Drug Dose Data 
 
The FDA’s MRTD database [41] was chosen to collect most of the drug doses because 
most of its values were determined from the results of pharmaceutical clinical trials. 
Values in this database are normalized for the average 60 kg adult. If the dose was not 
available in the database, then the dose listed in Micromedex [42], Lexicomp [43], or 
Newby et al. [39] was used. This database contains widely distributed doses, and there is 
no single delineator that can differentiate well-absorbed and poorly-absorbed 
compounds solely based on their dose value.  
 
4.3.5 Melting Points 
 
Most of the melting points for this study were collected from either the Merck Index [73], 
companies chemical catalogs, or the scientific literature. [74-239] The melting point 
values and references are given in supplementary material in Table A.2. If the 
experimental melting point is not available, then the decomposition temperature is used. 
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If the drug is marketed as a salt form, the melting point of its corresponding 
nonelectrolyte is used. If the experimental melting point is not available, then group 
contribution methods like UPPER can be utilized to calculate theoretical melting point 
(Chapter 5).  The lack of correlation between the experimental FA value and the 














































































































4.4 Results and Discussion  
 
According to Equation 4.10, both melting point and drug dose are important for calculating 
the melting point based absorption parameter (MP) The correlation between MP  and 
experimental FA for all drugs in suspension is shown in Figure 4.2. The horizontal line at 
FA=0.5 differentiates the well-absorbed (FA≥0.5) and poorly absorbed (FA<0.5) 
compounds. The vertical line at MP =0 is a delineator corresponding to Equation 4.11 



























































































































In other words, if a MP value is greater than zero, the compound is likely to be well 
absorbed. This Figure is divided into four quadrants. The 408 points in the upper right and 
16 points in lower left represent correct predictions. The 52 points in the lower right and 
26 points in upper left quadrants represent incorrect predictions.  
 
It is worth noting that the derivation of MP is based on the solubility product, which is 
applicable for drug concentrations that exceed their solubilities. However, in the early 
stage of drug design and development, neither the drug dose or its solubility are known. 
Fortunately, we have empirically observed that the application of MP, by Equation 4.12, 
to all compounds, without regard to whether they form solutions or suspensions in the 
gut (See Figure 4.3) gives similar results to those for suspensions (See Figure 4.2). 
Therefore, Equation 4.12 can be used to calculate the maximum well absorbable dose.  
 
This dose for 820 compounds is recorded in supplementary information in Table A.1. 
According to our results, overall 83% of the calculated maximum well-absorbed dose is 
correct. The relatively low number compounds in the lower left quadrant may be due to 























































































































Clearly, there is a correlation between the value of the fraction absorbed and MP, 
however, It is difficult to generate a single equation that can predict the relationship 
between FA and MP. For a better understanding of these data, the bar graph with 
standard errors is generated by plotting the average of the FA values within -0.5 and +0.5 
log units of the MP value. This curve is shown in Figure 4.4. In the left region, standard 
errors are large compared to the right regions. The bar label corresponds to the number 
of compounds that fall into that MP range. We can observe a sharp drop in Mean FA 
value between the MP value of -0.5 and +0.5.  
 
Using over 300 compounds, Newby et al. [39] also demonstrated that the model based 
on MP and the GSE solubility has higher accuracy than using experimental solubility, and 
it can be utilized to predict oral absorption. Recently, Duosani and Macheras [240] 
showed that how simple absorption parameter  can be utilized to understand 
complicated homogeneous and heterogeneous aspects of drug absorption kinetics.  
 
For a better understanding and to see the overall trend, mathematical treatment is 
performed on the whole dataset. Table 4.1 shows the relationship of average melting 
points to various mean properties used in this model. The mean properties calculated 
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Table 4.1. The Interrelationships Among Mean MP, Mean log 4D, Mean FA, 
and Mean MP 
 
Melting point range Total number 
of compounds 
Mean value 
MP log 4D FA MP 
Below 50 24 27 -2.42 0.88 2.90 
50 - 100 63 78 -2.41 0.90 2.38 
100 - 150 118 129 -2.54 0.82 2.00 
150 - 200 154 174 -2.43 0.78 1.44 
200 - 250 91 226 -2.59 0.74 1.07 
250 - 300 46 270 -2.37 0.68 0.41 












This model is based only on the experimental melting point and the dose; it does not 
account for the physiological conditions of the GI tract or the dissolution kinetics of the 
drug. This simple absorption parameter MP  can be utilized as an early screening tool for 
predicting the maximum well-absorbed dose. It can also be an aid in drug design to 























The simple and intuitive absorption parameter MP is a function of the drug dose and 
experimental melting point. If the value of the MP for the orally administered drug 
is greater than zero, it is likely to be well (> 50%) absorbed. The maximum well-
absorbed dose was predicted correctly for 424 out of total 502 drugs that form a 
saturated solution in the gastrointestinal tract (GI) at the administered dose. 
Interestingly, both experimental mean FA and calculated MP show a similar trend 
with an increase in mean MP. Therefore, the absorption parameter MP could be 
utilized as a pre-screening tool in the early stage of drug discovery. The maximum well 





















Classical barbiturates are formed by substituting one or both hydrogen atoms at the 5-
position with alkyl, aryl, and/or alicyclic groups. In this study, a previously developed 
UPPER (Unified Physicochemical Property Estimation Relationships) approach is applied 
to predict the melting points and aqueous solubilities of a series of barbiturates. The 
descriptors from a previously developed UPPER model on hydrocarbons are used to 
generate new descriptors for the barbiturate ring using multiple linear regression 
analysis. Melting points can be predicted solely from additive enthalpic and non-additive 
entropic descriptors. These predicted melting points and aqueous activity coefficients are 
used to predict the aqueous solubilities. Only three new parameters are added to predict 
the each of above properties. The average absolute errors in the prediction of melting 
points and aqueous solubilities are 20.6oC and 0.57 respectively. This simple and efficient 
UPPER approach can be useful for predicting melting points and aqueous solubilities of 
novel barbiturates and other compounds for which the experimental values are 
unavailable in the literature. The UPPER based solubility and melting point can be utilized 






Classical barbiturates are malonyl urea derivatives substituted at the five position with 
alkyl, aryl and/or alicyclic groups [241] (Figure 5.1). Since the introduction of barbiturates 
by Baeyer in 1864, more than 2500 derivatives have been synthesized, and a few of them 
are still being marketed [242]. The present work focuses on predicting the melting points 
and aqueous solubilities of the classical barbiturates from their chemical structures. 
 
Drug discovery is a very expensive and difficult process. In order to minimize the overall 
cost and speedup the process, many approaches have been developed to estimate 
physicochemical properties of drugs before they are synthesized [40,243].  The UPPER 
approach developed by Yalkowsky et al. [244] offers a rapid and inexpensive means of 
calculating melting points, vapor pressures, aqueous solubilities and other biorelevant 
properties.  
 
The melting point has wide application in the field of pharmaceutical, biochemical and 
environmental sciences because of its relationship with the solubility and vapor pressure 
[245]. Recently, Lian et al. used the UPPER model for predicting the melting point of  
hydrocarbons [246].  
 
The aqueous solubility is an important determinant of dissolution rate, absorption, and 
bioavailability. Poor aqueous solubility is a key problem during formulation development 
and drug design [247]. The GSE (General Solubility Equation) developed by Jain and 
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Yalkowsky requires the calculated octanol-water partition coefficient and the 
experimental melting point to predict the aqueous solubility [7]. Yalkowsky and Pinal used 
the GSE to calculate the aqueous solubility of several barbiturates [248].  
 
 In this chapter, we applied the UPPER model only to the classical barbiturates. As in 
these type of barbiturates, the general ring structure has only other substitution at five 
position is hydrocarbon moieties (Figure 5.1). Here, only UPPER model is used to predict 
the melting points while both UPPER and GSE models are used to calculate the aqueous 





































5.2 The UPPER Model for Melting Point Prediction 
 
Melting points Tm (K) are calculated using Equation 5.1. 
 
𝑇𝑚 =  
∆𝐻𝑚
∆𝑆𝑚
          (Equation 5.1) 
 
where ∆Hm is the total enthalpy of melting (kJ/mol), and ∆Sm is the total entropy of 
melting (J/K ∙ mol) as described below.  
 
5.2.1 Enthalpy of Melting 
The enthalpy of melting is defined as the total change in the enthalpy when one mole of 
a crystal is converted into a liquid. i.e., 
 
∆𝐻𝑚 =  𝐻
𝐿 − 𝐻𝐶          (Equation 5.2) 
 
where 𝐻𝐿is the molar enthalpy of a liquid phase and 𝐻𝑐 is the molar enthalpy of a crystal 
phase.  
 
The enthalpy of melting is an additive property that can be calculated by the sum of 
constituent group contributions as expressed in Equation 5.3. 
 




where ni is the number of times that group i appears in the compound, and mi is the 
contribution of group i to the total enthalpy of melting. 
5.2.2 Entropy of Melting  
 
The entropy of melting is defined as the change in the molar entropy when the crystal is 
converted into a liquid phase. Hence, 
 
∆𝑆𝑚 =  𝑆
𝐿 − 𝑆𝐶         (Equation 5.4) 
 
where 𝑆𝐿 is the molar entropy of a liquid phase and 𝑆𝑐 is the molar entropy of a crystal 
phase. Based on the Boltzmann equation, the molar entropy of melting is related to the 
logarithm of m, the ratio of the probabilities of existence of the crystal phase to that of 
the liquid phase.  That is 
 







         (Equation 5.6) 
 





The probability of achieving the crystal phase is equal to the number of ways in one mole 
of molecules can be arranged that conform to the requirements of a crystal, divided by 
the total number of ways in which all possible phases can exist.  In the case of a substance 





  and 𝑃𝐿 =
 Ω𝐿
(Ω𝐶+Ω𝐿)
      (Equation 5.7) 
 
where the numerators are the number of ways in which the crystal and liquid can be 
achieved, respectively and the denominator is the total number of ways in which the 
molecule can exist.   
 
Combining Equations 5.4 thru 5.7 gives, 
 
𝑆𝐶 = − 𝑅 ln
 Ω𝐶
(Ω𝐶+Ω𝐿)
 and 𝑆𝐿 = − 𝑅 ln
Ω𝐿
(Ω𝐶+Ω𝐿)
    (Equation 5.8) 
 
where R is the gas constant. 
 
Walden [12] estimated the entropy of melting of a variety of coal tar derivatives as 
approximately 57 J/Kmol (Walden’s Rule). This constant value of the entropy of melting 
is traditionally used for all organic compounds. However, deviations from Walden’s rule 
















𝑒𝑥𝑝𝑎𝑛      (Equation 5.9) 
 
Three geometric descriptors; symmetry (), flexibility () and eccentricity () are used in 
UPPER to characterize each type of entropic component, respectively. 
 
5.2.2.1 Rotational symmetry 
 
As described by Lian and Yalkowsky, the rotational symmetry () is defined as the number 
of positions into which a molecule can be placed that are identical to a reference position 
[246]. Since highly symmetrical molecules can crystallize more readily, they have lower 
entropies of melting. If the rotational symmetry number is incorporated as the probability 
ratio into the Boltzmann equation (Equation 5.5), then 
 
∆𝑆𝑚
𝑟𝑜𝑡 =  −𝑅 ln 𝜎                   (Equation 5.10) 
 
5.2.2.2 Molecular flexibility   
 
The molecular flexibility number (𝜙) is related to the ratio of the total number of possible 
conformations of a compound in the crystal to that of the liquid. The conformational 
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component of entropy is related to the molecular flexibility as highly flexible molecules 
can have many conformations in the liquid and are less likely to be in the single trans 
conformation of crystal. Thus, they tend to have higher entropies of melting. By 




𝑟𝑜𝑡 =  −𝑅 ln 𝜙                   (Equation 5.11) 
 
For a hypothetical long chain normal alkane with completely free bond rotation (assuming 
equal energies for the trans and two gauche conformations), the probability of being in 
the all-trans form would be 0.33. According to Wunderlich [250], the trans conformation 
is more stable than the gauche conformation by 2.09 KJ/mol, and certain combinations 
of adjacent gauche conformations would place two atoms in the same place. Correcting 
for these effects gives the overall probability of a molecule being in the all trans form is  
 
𝜙 = (0.4)Φ                    (Equation 5.12) 
 
where , the effective number of torsional units in the molecule. 
 
In UPPER, this effective number of torsional units is calculated using Equation 5.13. 
 
Φ = LIN + 0.3 ROT* + 0.5(BR + SP2 + RING) - 1                (Equation 5.13)     
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where LIN is the sum of all non-ring, non-terminal sp3 atoms; ROT* is the sum of all freely 
rotating linear chain sp3 atoms less 4 (e.g. Octane has six linear chain sp3 atoms, so ROT* 
value is 2); BR is the sum of all branched, non-ring sp3 atoms; SP2 is the sum of all non-
ring, non-terminal sp2 atoms; RING is the total number of independent single, fused or 
conjugated aromatic rings present in the molecule.  
 
5.2.2.3 Molecular eccentricity 
 
Molecular eccentricity () is defined as the total number of atoms in the aromatic and/or 
aliphatic rings. It is related to the packing efficiency of molecules in the crystal, and thus, 
to the amount of expansion required for melting.  Since highly eccentric molecules are 
more likely to pack efficiently in the crystal, they need more expansion to from a liquid. 
This gives them a higher entropy of melting. By substituting the probability ratio of the 
Boltzmann equation with the eccentricity, we get 
 
∆𝑆𝑚
𝑒𝑥𝑝𝑎𝑛 =  𝑅 𝑙𝑛 𝜀                      (Equation 5.14) 
 
Using Equation 5.9, 5.10, 5.11, and 5.14, the total entropy of melting can be described as 
 
∆𝑆𝑚 = 𝑊′ − 𝑅 ln − 𝑅 ln 𝜙 + 𝑅 ln 𝜀                 (Equation 5.15) 
 
where 𝑊′ is the modified Walden’s Rule constant. 




∆𝑆𝑚 = 𝑊′ − 19.1 log 𝜎 + 7.6 Φ + 19.1 log 𝜀               (Equation 5.16) 
 
As described by Lian and Yalkowsky [246], deviation from ideal entropy of melting is 
common, the entropy of melting for hydrocarbons can be well described by the following 
empirical equation   
 
∆𝑆𝑚 = 43.54 − 8.95 log 𝜎 + 7.93 Φ + 9.16 log 𝜀𝑎𝑟 + 9.43 log 𝜀𝑎𝑙   Equation 5.17) 
 
where 𝜀𝑎𝑟 and 𝜀𝑎𝑙  are the molecular eccentricity contribution for the aromatic and the 
aliphatic rings respectively. 
 
The lower coefficients in Equation 5.17 reflect the fact that the crystal is not a perfect 
crystal and the liquid is not a perfect liquid. 
 
5.3 The UPPER Model for Intrinsic Solubility Prediction 
 
5.3.1 Ideal Solubility 
 
The ideal solubility of a crystalline solute, 𝑋𝑖
𝐶 , is its solubility in a hypothetical perfect 
solvent, i.e., one in which the solute-solvent interactions are exactly equal to the sum of 
the solute-solute and solvent-solvent interactions.  It is entirely dependent on the 
crystallinity of the solute and independent of the solvent.  The ideal solubility can be 
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thought of as the ratio of the solubility of a crystal in any solvent to the solubility of its 
hypothetical supercooled liquid in the same solvent. The ideal solubility is approximated 
from the Clausius-Clapeyron equation or the Van’t Hoff equation, both of which can be 
expressed as Equation 5.18 [7], 
 
𝑙𝑜𝑔𝑋𝑖
𝐶 = −∆𝑆𝑚  
(𝑇𝑚−𝑇)
2.303 𝑅 𝑇
                    (Equation 5.18) 
 
where T and Tm are the room temperature and melting point in Kelvin, and R is the gas 
constant. 
 
5.3.2 Approximate Ideal Solubility 
 
Incorporating Walden’s Rule (Sm=57 J/K mol) into the above equation gives, 
 
𝑙𝑜𝑔𝑋𝑖
𝐶 = −0.01 (𝑇𝑚 − 𝑇)                    (Equation 5.19) 
 
which can be written in Celsius as, 
 
𝑙𝑜𝑔𝑋𝑖







5.3.3 Aqueous Activity Coefficient 
 
The logarithm of the aqueous activity coefficient log w (like the enthalpy of melting) is a 
group additive property. Myrdal and Yalkowsky developed the AQUAFAC (AQUeous 
Functional group Activity Coefficients) model to calculate the total logarithmic aqueous 
activity coefficient by adding all group contribution as expressed in Equation 5.21 [251]. 
 
log w = ∑ niqi                    (Equation 5.21) 
 
where ni is the number of times that group i appears in a compound and qi is the 
contribution of group i to the total logarithmic aqueous activity coefficient. 
 
 
5.3.4 Aqueous Solubility 
 
The molar aqueous solubility (Sw) is the ratio of the ideal solubility of a solute to its 
aqueous activity coefficient [252]. In logarithmic terms it is, 
 
log 𝑆𝑤 = 𝑙𝑜𝑔 𝑋𝑖
𝑐 − 𝑙𝑜𝑔 𝛾𝑤                    (Equation 5.22) 
 
where 𝑙𝑜𝑔 𝑋𝑖







5.4.1 Data collection 
 
The reported experimental melting point and aqueous intrinsic solubility values of 44 5-
substituted barbiturates were collected from Prankerd and McKeown [253], Pinal and 
Yalkowsky [248], Hughes et al. [254], and the Merck Index [11] are listed in Table 5.1. This 
table includes the melting points (which range between 364 K to 561 K) and aqueous 
molar intrinsic solubilities (which range between 3.45 E-5 M to 0.12 M). The partition 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In Tables 5.2 and 5.3, the first column shows the atomic composition of the groups 
considered and the first row gives the following the environmental descriptors.  
X   the group is bonded only to sp3 hybrid atoms;  
Y   the group is singly bonded to sp2 hybrid atom;  
RG  the group is within an aliphatic ring;  
AR  the group is within aromatic ring; 
FU  the group is a bridge-head in an aliphatic ring system;  
H  the group is bonded to H atom 


















Table 5.2 Group Contribution Coefficients (J/mol) for the Calculation of Total 
Enthalpy of Melting 
 
Group X Y RG AR FU H 
-CH3 1183 1785 - - - - 
-CH2 1906 684 1319 - - - 
-CH2* 4000 - - - - - 
-CH 1047 -1545 836 1387 1127 - 
-C -85 -2246 -519 1219 1152 - 
=CH2 1371 - - - - - 
=CH 1667 1399 973 - - - 
=C 1296 -1005 531 - - - 















Table 5.3 Group Contribution Coefficients for the Calculation of Total 
Logarithm Aqueous Activity 
Group X Y RG AR FU H 
-CH3 0.958 0.711 - - - - 
-CH2 0.687 0.334 0.520 - - - 
(-CH2)2 -0.018 - - - - - 
-CH -0.100 -0.342 0.254 0.312 0.513 - 
-C -0.662 -0.890 -0.291 0.112 - - 
=CH2 0.627 - - - - - 
=CH 0.284 0.290 0.269 - - - 
=C -0.044 -0.230 0.087 - - - 















Each compound was broken down into the groups using the same molecular 
fragmentation scheme described by Lian and Yalkowsky [246]. Microsoft Excel 2012 was 
used to perform all calculations for group counts, enthalpies of melting, entropies of 
melting, and aqueous activity coefficients. The barbiturate compounds are subdivided 
into three different groups based on whether they contain hydrogen, only sp3 atoms or 
at least one sp2 atoms at 5-position. These are designated as H-Barb, X-Barb, and Y-Barb, 
respectively (Figure 5.1). The mi and qi contributions of barbiturate rings were generated 
by subtracting the hydrocarbon group values in Tables 5.2 and 5.3 from the observed 
values. 
 
5.4.2 Calculation of Melting Point by UPPER 
 
For each compound, the total entropy of melting (∆Sm) was estimated by Equation 5.17.  
The total enthalpy of melting (∆Hm) for each barbiturate compound was calculated by 
multiplying the experimental melting point (𝑇𝑚
𝑂𝑏𝑠) by the calculated entropy of melting. 
The enthalpy of hydrocarbon groups (∑𝑛𝑖𝑚𝑖) were obtained from Lian and Yalkowsky 
[246]. The mean enthalpy 𝑚𝑖
𝑏𝑎𝑟𝑏 values for H-Barb, X-Barb, and Y-Barb (Table 5.2.) were 
obtained from the difference between the calculated total enthalpy and the sum of the 
hydrocarbon values. Finally, the total enthalpies for predicting melting point were 
obtained by adding the calculated 𝑚𝑖
𝑏𝑎𝑟𝑏 value to the hydrocarbon group values. These 
calculated enthalpy and entropy values were used to calculate melting point 𝑇𝑚
𝐶𝑎𝑙𝑐 via 











43.54−8.95 log 𝜎+7.93 Φ+9.16 log 𝜀𝑎𝑟+9.43 log 𝜀𝑎𝑙
              (Equation 5.23) 
 
where 𝑚𝑖
𝑏𝑎𝑟𝑏 is the group contribution value for one of the three above-mentioned 
barbituric acid rings to the total enthalpy of melting. 
 
5.4.3 Calculation of Solubility by UPPER 
 
The effect of solute crystallinity is determined by incorporating the calculated entropy of 
melting and the calculated melting point into Equation 5.18.  The aqueous activity 
coefficient for each compound was calculated by adding the 𝑞𝑖
𝑏𝑎𝑟𝑏 value for the ring to 




 = − 
(43.54−8.95 log 𝜎+7.93 Φ+9.16 log 𝜀𝑎𝑟+9.43 log 𝜀𝑎𝑙) (𝑇𝑚
𝐶𝑎𝑙𝑐−𝑇)
2.303 𝑅𝑇
− ( ∑𝑛𝑖𝑞𝑖 + 𝑞𝑖
𝑏𝑎𝑟𝑏) 
                      (Equation 5.24) 
 
The total aqueous activity coefficient for each barbiturate compound was calculated using 
Equation 5.21. The aqueous activity coefficients of the hydrocarbon groups (∑𝑞𝑖𝑚𝑖) were 
calculated by adding group 𝑞𝑖  values from Lian and Yalkowsky [246]. The aqueous activity 
coefficients 𝑞𝑖
𝑏𝑎𝑟𝑏 values for H-Barb, X-Barb, and Y-Barb (Table 5.3) were obtained from 
the difference between calculated total aqueous activity coefficient and the sum of the 
hydrocarbon values. As shown in Equation 5.24, the final calculated log w for predicting 
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solubility was obtained by adding the 𝑞𝑖
𝑏𝑎𝑟𝑏 values and other substituted group values 
and these values were used to calculate log 𝑆𝑤
𝐶𝑎𝑙𝑐.  
 
5.4.4 Calculation of Solubility by the GSE 
 
The General Solubility Equation (GSE) of Yalkowsky provides a simple means of estimating 
the aqueous solubility of nonelectrolytes in which the logarithm of the octanol-water 
partition coefficient is used to represent the aqueous activity coefficient, and Equation 
5.20 is used as the ideal solubility. Thus, 
 
log 𝑆𝑤 = 0.5 – log P - 0.01 (𝑀𝑃- 25)                 (Equation 5.25) 
 













5.5 Results and Discussion 
 
5.5.1 Melting Point   
 
The observed and predicted melting points of the barbiturates are shown in Figure 5.2. 
Note that the negative and positive residual values of Table 5.1 correspond to 
underestimates and overestimates in the prediction, respectively. In order to calculate 
the total enthalpy of classical barbiturates, we need to calculate enthalpic group 
contribution of the barbiturate ring as the UPPER model of hydrocarbons does not 
account for the non-hydrocarbon moiety. The melting points were generated by 
incorporating the group mi values of Lian and Yalkowsky along with the appropriate 
barbituric acid ring coefficient. Note that these three 𝑚𝑖
𝑏𝑎𝑟𝑏 values are the only 
regression- generated enthalpic parameters used to predict melting points. The average 



















































































































































































5.5.2 Aqueous Solubility 
 
The observed and predicted logarithms of the aqueous solubility by the UPPER model are 
shown in Figure 5.3. Again, the new entropic descriptors and only one of the three fitted 
𝑞𝑖
𝑏𝑎𝑟𝑏 values used to predict solubility of each compound.  The average absolute error for 
predicting aqueous solubility using the UPPER and GSE models are 0.57 and 0.38, 
respectively.  As shown in Figure 5.3, these predicted solubility values are in a good 
agreement with the experimental values. As expected, the GSE model can predict the 
solubility of barbiturates more accurately, as it uses observed melting point, which might 
not be available for all compounds in the early stages of drug discovery. UPPER, on the 

























































































































































Table 5.4 Statistical Results for Melting Point and Aqueous Solubility 
 
Properties Average Absolute Error  
𝑻𝒎
𝑪𝒂𝒍𝒄 20.6  
log 𝑺𝒘
𝑪𝒂𝒍𝒄 by UPPER 0.57  
log 𝑺𝒘






















The UPPER model, which is developed on the basis of simple hydrocarbons is applied to 
barbiturates. The prediction of properties is directly based on the chemical structure and 
well-known thermodynamic relationships. It is clear from the results listed in Table 5.4 
that there is a good agreement between the predicted and observed values. Thus, this 
simple and efficient approach could be useful for predicting melting points and aqueous 
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